| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |